Multiple Cox regression analysis performed to adjust for prognostic covariates (BRAF genotype and tumour sidedness) disclosed a significant decrease in OS for patients with the p.V600E variant (p = 0.029) but not with loss of CDX2 expression (Table 4). This evidence concerns the gene BRAF and neoplasm.